Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.

Detalles Bibliográficos
Main Authors:	Semmo, N, Lucas, M, Krashias, G, Lauer, G, Chapel, H, Klenerman, P
Formato:	Journal article
Idioma:	English
Publicado:	2006

Títulos similares

Methodologies for the analysis of HCV-specific CD4(+) T cells
por: Lokhande, M, et al.
Publicado: (2015)

Methodologies for the analysis of HCV-specific CD4+ T cells
por: Megha eLokhande, et al.
Publicado: (2015-02-01)

HCV-specific T-CELL responses of acutely HCV infected individuals with and without HIV.
por: Danta, M, et al.
Publicado: (2005)

HCV-indeterminate blood donors or occult HCV infection? Reply
por: Semmo, N, et al.
Publicado: (2005)

T-cell responses during early therapy for HCV infection.
por: Lauer, G, et al.
Publicado: (2003)

Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
por: Semmo, N, et al.
Publicado: (2007)

Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
por: Lauer, G, et al.
Publicado: (2001)

Cellular immune responses against HCV: T cells take a diversion in the liver
por: Klenerman, P, et al.
Publicado: (2004)

HIV has a significant impact on the early HCV host-viral responses
por: Danta, M, et al.
Publicado: (2006)

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.
por: Semmo, N, et al.
Publicado: (2005)

Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
por: Mueller, M, et al.
Publicado: (2010)

Primary antibody deficiency in adults.
por: Spickett, G, et al.
Publicado: (1991)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution
por: Kasprowicz, V, et al.
Publicado: (2011)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.
por: Kasprowicz, V, et al.
Publicado: (2010)

Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.
por: Chapel, H
Publicado: (1994)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
por: Humphreys, IS, et al.
Publicado: (2012)

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
por: Jolles, S, et al.
Publicado: (2016)

HCV genotype-3a T cell immunity: Specificity, function and impact of therapy
por: Humphreys, I, et al.
Publicado: (2012)

HCV genotype-3a T cell immunity: specificity, function and impact of therapy.
por: Humphreys, I, et al.
Publicado: (2012)

Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (vol 84, pg 1656, 2010)
por: Kasprowicz, V, et al.
Publicado: (2011)

CORRELATION BETWEEN THE ANTIBODY RESPONSE TOWARD SPECIFIC HCV PROTEINS AND HCV VIRAL LOAD
por: Chiydem Ismailova, et al.
Publicado: (2021-04-01)

CTL epitope escape and reversion in acute HCV infection.
por: Timm, J, et al.
Publicado: (2004)

The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden
por: Lei Zhang, et al.
Publicado: (2019-11-01)

MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES
por: Boehmer, A, et al.
Publicado: (2011)

Comprehensive longitudinal analysis of cellular immune responses and viral evolution in a person with acute HCV infection requiring antiviral treatment.
por: Lauer, G, et al.
Publicado: (2002)

Detection rate of specific antibodies to the HCV CORE+1 protein in “naive” cronically HCV-infected patients in depends on the stage of liver fibrosis and the HCV subtype
por: E. V. Lichnaya, et al.
Publicado: (2021-01-01)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
por: Daniel Sepúlveda-Crespo, et al.
Publicado: (2024-08-01)

Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.
por: Harcourt, G, et al.
Publicado: (2006)

CD8AA T CELLS: A NOVEL LINEAGE ENRICHED IN THE LIVER IN CHRONIC HCV
por: Walker, L, et al.
Publicado: (2010)

Immune responses in acute and chronic HCV genotype 3a infection detected by two distinct techniques
por: von Delft, A, et al.
Publicado: (2011)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Hendrik Luxenburger, et al.
Publicado: (2018-11-01)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
por: Kasprowicz, V, et al.
Publicado: (2011)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
por: Kasprowicz, V, et al.
Publicado: (2008)

IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
por: Bucci, C, et al.
Publicado: (2011)

SPECIFIC ANTIBODY DEFICIENCY IN CHILDREN SUFFERING RECURRENT INFECTIONS
por: M. Naseri. G.P. Spickett, et al.
Publicado: (1999-09-01)

SPECIFIC ANTIBODY DEFICIENCY IN CHILDREN SUFFERING RECURRENT INFECTIONS
por: M. Naseri. G.P. Spickett, et al.
Publicado: (1999-08-01)

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
por: von Delft, A, et al.
Publicado: (2015)

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity.
por: Pfafferott, K, et al.
Publicado: (2011)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
por: Rohrbach, J, et al.
Publicado: (2010)

Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles.
por: Yao Deng, et al.
Publicado: (2013-01-01)